Senseonics Holdings (SENS) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

-$0.50

Estimate

-$0.53

Surprise

+5.1%

Revenue (period 2026-09-30)

$19.6M

Score at report (before → after)

6.2 → 6.6/10

Revenue source: xbrl.

Senseonics Holdings (SENS) reported a narrower loss than forecast — adjusted EPS of -$0.50 against the -$0.53 estimate (a 5.1% beat on a still-unprofitable quarter). TrendMatrix's engine moved from Sell (6.2/10) to Hold at 6.6/10 after the report.

• Mizuho Maintains Outperform on Senseonics Holdings, Raises Price Target to $20 — benzinga, 2026-11-10
• TD Cowen Maintains Buy on Senseonics Holdings, Raises Price Target to $17 — benzinga, 2026-11-10
• Senseonics Stock Rises Tuesday on Strong Q3 Revenue, Raised 2026 Outlook — benzinga, 2026-11-10

TrendMatrix currently rates SENS Hold at 6.6/10.

1 of the last 4 quarters beat the estimate; this quarter's +5.1% surprise compares with a -0.9% four-quarter average. Next scheduled report: 2027-03-01.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$10.03

Price target

$12.98

Stop

$9.33

Upside to target

+29.4%

Reward-to-risk

2.0:1

Model outputs from TrendMatrix’s engine as of 2026-11-11 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Devices

Market cap

$530.3M

P/E (fwd)

-5.3

52-week range

$4.79–$13.98

Off 52-week high

28.2%

RSI (14)

65

Volume vs avg

5.38×

Score today

6.6/10